By Dorothy Atkins ( September 5, 2017, 9:54 PM EDT) -- Novo Nordisk Inc. has agreed to pay at least $60 million to end a federal investigation into its marketing practices and resolve seven whistleblower suits alleging the pharmaceutical company misled physicians and insurers about its hit Type 2 diabetes drug Victoza, the U.S. Department of Justice said Tuesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.